Health News Roundup: Executive Orders, Vaccine Warnings, and Medical Acquisitions
The latest health news highlights Trump considering an executive order to protect gas stoves, warnings for GSK's and Pfizer's RSV vaccines over neurological risks, and the first US bird flu death. Key developments also include Merck's HPV vaccine approval in China, J&J's cancer treatment success, and Stryker's acquisition of Inari Medical.
In a controversial move, President-Elect Donald Trump is contemplating an executive order aimed at safeguarding gas-powered appliances from potential regulations, insiders say. This comes amid a backdrop of Republican criticism towards efforts by local Democrats to curb these appliances due to environmental and health reasons.
In vaccine news, both GSK and Pfizer's RSV vaccines will now include warnings about the risk of Guillain-Barré syndrome, as revealed by a recent FDA postmarketing study. These warnings follow findings that indicated an increased risk of the neurological disorder following vaccination.
The World Health Organization has reassured that bird flu risk remains low despite the first US death from H5N1. Meanwhile, other significant developments include Merck obtaining approval for its HPV vaccine for men in China, and Johnson & Johnson's combination cancer treatment showing promising results against AstraZeneca's medication.
(With inputs from agencies.)
- READ MORE ON:
- Trump
- RSV vaccines
- bird flu
- Merck
- J&J
- HPV vaccine
- Stryker
- Inari Medical
- FDA
- blood oxygen monitors
ALSO READ
Stryker's $4.9 Billion Bet on Inari Medical: Expanding Horizons in Venous Disease Treatment
Stryker Set to Acquire Inari Medical: A Market Expansion in Venous Treatments
Stryker Eyes Strategic Expansion with Inari Medical Acquisition
Stryker's Strategic Acquisition Talks with Inari Medical
Merck's HPV Vaccine Gains Approval in China for Men